---
title: 'ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology
  and molecular biology and early, advanced and recurrent disease'
date: '2024-02-02'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38307807/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240203170625&v=2.18.0
source: heidelberg[Affiliation]
description: The European Society of Gynaecological Oncology, the European Society
  for Medical Oncology (ESMO) and the European Society of Pathology held a consensus
  conference (CC) on ovarian cancer on 15-16 June 2022 in Valencia, Spain. The CC
  panel included 44 experts in the management of ovarian cancer and pathology, an
  ESMO scientific advisor and a methodologist. The aim was to discuss new or contentious
  topics and develop recommendations to improve and harmonise the management of patients
  with ...
disable_comments: true
---
The European Society of Gynaecological Oncology, the European Society for Medical Oncology (ESMO) and the European Society of Pathology held a consensus conference (CC) on ovarian cancer on 15-16 June 2022 in Valencia, Spain. The CC panel included 44 experts in the management of ovarian cancer and pathology, an ESMO scientific advisor and a methodologist. The aim was to discuss new or contentious topics and develop recommendations to improve and harmonise the management of patients with ...